Michael May, Pancreas Cancer Clinical Investigator at Memorial Sloan Kettering Cancer Center, shared an update from Brandon Huffman, GI medical oncologist at Dana-Farber, on X, adding:
“Looking forward to joining Dr. Huffman Dana-Farber today for a meaningful discussion on extending therapeutic breakthroughs in pancreatic cancer to older adults, and what we are doing Memorial Sloan Kettering Cancer Center to refine our treatment algorithm for these people.”
Quoting Brandon Huffman:
“Join us at 12PM EST for a patient-centric webinar on the landscape for RAS inhibitors in older individuals with pancreatic cancer.”
This also can be interesting: ESMO Clinical Practice Guideline Express Update: Daraxonrasib for Metastatic Pancreatic Cancer
